Aneel Ashrani
Overview
Explore the profile of Aneel Ashrani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
607
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McBane 2nd R, Loprinzi C, Zemla T, Tafur A, Sanfilippo K, Liu J, et al.
J Thromb Haemost
. 2024 Dec;
23(2):756.
PMID: 39709266
No abstract available.
2.
Navarro S, Ashrani A, Park M, Chen D
J Chest Surg
. 2024 Oct;
58(1):46-49.
PMID: 39434611
Hermansky-Pudlak syndrome (HPS), both alone and in conjunction with pulmonary fibrosis (HPS-PF), is a rare, genetically heterogeneous, autosomal recessive disorder that affects multiple organs, including the lungs. In cases of...
3.
Streiff M, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, et al.
J Natl Compr Canc Netw
. 2024 Sep;
22(7):483-506.
PMID: 39236759
The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease provide strategies for the prevention, diagnosis, and treatment of venous thromboembolism (VTE) in adult patients with cancer. VTE is a common and...
4.
Chohan K, Pruthi R, Zanwar S, Paludo J, Go R, Pardanani A, et al.
Leukemia
. 2024 Aug;
38(11):2497-2500.
PMID: 39198620
No abstract available.
5.
McBane 2nd R, Loprinzi C, Zemla T, Tafur A, Sanfilippo K, Liu J, et al.
J Thromb Haemost
. 2024 Mar;
22(6):1704-1714.
PMID: 38537780
Background: Cancer-associated venous thromboembolism (VTE) management guideline recommendations include continued therapeutic anticoagulation while active cancer persists. The Federal Drug Administration label for apixaban for secondary VTE prevention includes a dose...
6.
Saadalla A, Chen D, Stuart M, Pruthi R, Heikal N, Snyder M, et al.
Int J Lab Hematol
. 2024 Feb;
46(4):695-704.
PMID: 38380742
Background: Clot based assays used for lupus anticoagulant (LAC) detection are typically interpreted in a qualitative fashion and may not reflect LAC potency. In this cross-sectional study, we describe a...
7.
Houghton D, Wysokinski W, Padrnos L, Shah S, Wysokinska E, Pruthi R, et al.
Am J Hematol
. 2023 Jan;
98(4):566-570.
PMID: 36660880
Patients with thrombophilia remain concerned about venous thromboembolism (VTE) risk with COVID-19 vaccinations. The aim of this study was to examine VTE outcomes in patients with inherited or acquired thrombophilia...
8.
Houghton D, Ashrani A, Liedl D, Mehta R, Hodge D, Rooke T, et al.
Vasc Med
. 2022 Sep;
28(1):57-58.
PMID: 36178146
No abstract available.
9.
Saadalla A, Stuart M, Ashrani A, Pruthi R, Morava E, Chen D, et al.
Int J Lab Hematol
. 2022 Aug;
45(1):e6-e9.
PMID: 35946440
No abstract available.
10.
Houghton D, Wysokinski W, Casanegra A, Padrnos L, Shah S, Wysokinska E, et al.
J Thromb Haemost
. 2022 Apr;
20(7):1638-1644.
PMID: 35398975
Background: COVID-19 vaccinations in the United States are effective in preventing illness and hospitalization yet concern over post-vaccination venous thromboembolism (VTE) risk has led to vaccine hesitancy. Methods: The aim...